CD166 Regulates Human and Murine Hematopoietic Stem Cell Function and the Hematopoietic Niche
CD166 调节人和小鼠造血干细胞功能和造血生态位
基本信息
- 批准号:10339403
- 负责人:
- 金额:$ 35.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:ALCAM geneActivities of Daily LivingBiologyCell CommunicationCell surfaceCellsCompetenceCytokine SignalingDataDefectENG geneElementsEndosteumEndothelial CellsEngraftmentEpigenetic ProcessGenesGenetic ModelsHematological DiseaseHematopoiesisHematopoieticHematopoietic SystemHematopoietic stem cellsHomeHumanImmobilizationImmunoglobulinsIncubatedInvestigationKnockout MiceLigandsMaintenanceMarrowMediatingMesenchymal Stem CellsMitochondriaMusOsteoblastsPECAM1 genePTPRC genePathway interactionsPhenotypePlatelet-Derived Growth Factor alpha ReceptorPlayProteinsPublishingRegulationResearchResearch PersonnelRoleSLAM proteinSignal PathwayStem cell pluripotencySurfaceTestingTimeTranslational ResearchTreesWild Type Mousebaseblood treatmentcell typeexhaustionfitnesshematopoietic stem cell nichehematopoietic stem cell self-renewalimprovedin vitro Assayin vivoinnovationknockout animalmembernestin proteinreceptorsingle-cell RNA sequencingstemstem cell functionstem cells
项目摘要
The phenotypic makeup and functional capacity of murine and human hematopoietic stem cells (HSC) has
been exhaustively investigated making HSC one of the most-characterized groups of cells in mammalian
biology. Still, not a single functional marker has been previously identified that is common to both murine and
human HSC while being also expressed on at least three important cellular components of the hematopoietic
niche (HN), namely osteoblasts (OB), endothelia cells (EC), and mesenchymal stem cells (MSC). Our focus on
CD166 began when we first established that CD166 identifies OB that mediate a hematopoiesis enhancing
activity. We also published that CD166 is expressed on normal murine and human HSC and plays a key role in
determining their functional capacity and the competence of the HN. We recently confirmed that CD166 is
expressed on a subset of EC and nestin+ MSC. Since CD166 is capable of mediating hetero- and homophilic
cell-cell interactions, we propose that CD166 serves as both ligand and receptor of HSC interactions with
cellular elements of the niche and is an important regulator of the competence of the HN and of stem
cell function. HSC from CD166-/- mice engraft poorly in lethally irradiated hosts. On the other hand CD166-/-
mice do not support the engraftment of LT-HSC suggesting that loss of CD166 abrogates the competence of
the HN. Marrow-homed LSK cells from wildtype (WT) donors lodged closer to the endosteum of host mice than
similar cells from knockout (KO) animals suggesting that engraftment is adversely impacted by the lack of
HSC-OB homophilic CD166-interactions7. Single-cell RNAseq analysis of WT and CD166-/- CD150+CD48- LSK
cells incubated with immobilized CD166 protein revealed that engagement of CD166 on these cells activated
cytokine signaling, epigenetic pathways, stem cell pluripotency genes, and mitochondria-related signaling
pathways. Based on these findings, we hypothesize that CD166 is a functional marker required for HSC-
niche interactions that support the competence of the hematopoietic niche. We also believe that
preferential CD166 homophilic interactions in the niche contribute to HSC regulation and maintenance
of the hematopoietic potential of stem cells. We will test these hypotheses by investigating 2 aims: 1) Test
the hypothesis that CD166 expression on OB, EC, and MSC in the hematopoietic niche is required for the
competence of the hematopoietic niche and 2) Test the hypothesis that hematopoietic stem cells lacking
CD166 homophilic interactions with OB, EC, and MSC in the niche fail to develop normally and acquire an
engraftment defect. The significance of this proposal is that it will examine the role of a new and unique
functional marker of human and murine HSC and will investigate the impact of CD166 modulation on stem cell
function. The novelty of this proposal stems from its potential to implicate CD166 in the regulation of the HN
and HSC that reside in and interact with CD166-rich cellular elements of this microenvironment. These studies
have the potential to define how homophilic CD166 interactions promote HSC self-renewal.
小鼠和人造血干细胞(HSC)的表型组成和功能能力具有
已被彻底研究,使HSC成为哺乳动物中最具特征的细胞群之一,
生物学尽管如此,以前还没有鉴定出一种单一的功能性标记物是鼠和人共同的。
人HSC同时也在造血干细胞的至少三种重要细胞组分上表达,
小生境(HN),即成骨细胞(OB)、内皮细胞(EC)和间充质干细胞(MSC)。我们专注于
当我们首次确定CD 166识别OB介导造血增强时,CD 166开始。
活动我们还发表了CD 166在正常鼠和人HSC上表达,并在HSC的增殖和分化中起关键作用。
确定他们的职能能力和东道国的能力。我们最近证实,CD 166是
在EC和巢蛋白+ MSC的子集上表达。由于CD 166能够介导异嗜性和同嗜性
细胞-细胞相互作用,我们提出,CD 166作为HSC相互作用的配体和受体,
细胞元件的生态位,是一个重要的调节能力的HN和干
细胞功能来自CD 166-/-小鼠的HSC在致死辐射的宿主中移植不良。CD166-/-
小鼠不支持LT-HSC的植入,这表明CD 166的缺失消除了LT-HSC的能力。
的HN。来自野生型(WT)供体的骨髓归巢的LSK细胞比来自野生型(WT)供体的骨髓归巢的LSK细胞更靠近宿主小鼠的骨内膜。
来自敲除(KO)动物的类似细胞表明,植入受到缺乏
HSC-OB嗜同性CD 166-相互作用7. WT和CD 166-/-CD 150 + CD 48- LSK的单细胞RNAseq分析
与固定化的CD 166蛋白孵育的细胞显示,这些细胞上的CD 166的接合激活了
细胞因子信号传导、表观遗传途径、干细胞多能性基因和与细胞因子相关的信号传导
途径。基于这些发现,我们假设CD 166是HSC-1表达所需的功能性标志物。
支持造血生态位能力的生态位相互作用。我们也相信
在小生境中优先的CD 166嗜同性相互作用有助于HSC的调节和维持
干细胞的造血潜能。我们将通过调查2个目标来测试这些假设:1)测试
假设造血微环境中OB、EC和MSC上的CD 166表达是造血干细胞增殖所必需的,
能力的造血生态位和2)测试的假设,造血干细胞缺乏
CD 166与OB、EC和MSC在小生境中的嗜同性相互作用不能正常发育,
植入缺陷。这项建议的意义在于,它将审查一个新的、独特的
人和小鼠HSC的功能标记,并将研究CD 166调节对干细胞的影响
功能该提议的新奇源于其可能涉及CD 166对HN的调节。
和HSC,它们驻留在该微环境中富含CD 166的细胞成分中并与之相互作用。这些研究
有可能确定嗜同性CD 166相互作用如何促进HSC自我更新。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melissa A Kacena其他文献
Melissa A Kacena的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melissa A Kacena', 18)}}的其他基金
"Novel therapeutic approaches to improve fracture healing while reducing pain behavior"
“改善骨折愈合同时减少疼痛行为的新治疗方法”
- 批准号:
10609035 - 财政年份:2022
- 资助金额:
$ 35.44万 - 项目类别:
"Novel therapeutic approaches to improve fracture healing while reducing pain behavior"
“改善骨折愈合同时减少疼痛行为的新治疗方法”
- 批准号:
10426446 - 财政年份:2022
- 资助金额:
$ 35.44万 - 项目类别:
Osteomacs and megakaryocytes interact to regulate hematopoietic stem cell function
骨巨细胞和巨核细胞相互作用调节造血干细胞功能
- 批准号:
10212373 - 财政年份:2019
- 资助金额:
$ 35.44万 - 项目类别:
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging - LOAD
血管生成疗法:增强衰老过程中骨再生的新方法 - LOAD
- 批准号:
10711847 - 财政年份:2019
- 资助金额:
$ 35.44万 - 项目类别:
Osteomacs and megakaryocytes interact to regulate hematopoietic stem cell function
骨巨细胞和巨核细胞相互作用调节造血干细胞功能
- 批准号:
9764740 - 财政年份:2019
- 资助金额:
$ 35.44万 - 项目类别:
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging - AD/ADRD
血管生成疗法:增强衰老过程中骨再生的新方法 - AD/ADRD
- 批准号:
10711880 - 财政年份:2019
- 资助金额:
$ 35.44万 - 项目类别:
ShEEP Request for a Kubtec XPERT 80 Shielded Cabinet X-ray System
ShEEP 请求 Kubtec XPERT 80 屏蔽柜 X 射线系统
- 批准号:
9796215 - 财政年份:2019
- 资助金额:
$ 35.44万 - 项目类别:
Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging
血管生成疗法:增强衰老过程中骨再生的新方法
- 批准号:
9757972 - 财政年份:2019
- 资助金额:
$ 35.44万 - 项目类别:
Osteomacs and megakaryocytes interact to regulate hematopoietic stem cell function
骨巨细胞和巨核细胞相互作用调节造血干细胞功能
- 批准号:
10686056 - 财政年份:2019
- 资助金额:
$ 35.44万 - 项目类别:
相似海外基金
Determining 4-Dimensional Foot Loading Profiles of Healthy Adults across Activities of Daily Living
确定健康成年人日常生活活动的 4 维足部负荷曲线
- 批准号:
2473795 - 财政年份:2024
- 资助金额:
$ 35.44万 - 项目类别:
Studentship
Developing a trunk function assessment for hemiplegics. -For improving activities of daily living-
开发偏瘫患者的躯干功能评估。
- 批准号:
23K10540 - 财政年份:2023
- 资助金额:
$ 35.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Relation with the activities of daily living and the subjective values among people with social withdrawal
社交退缩者日常生活活动与主观价值观的关系
- 批准号:
23K16596 - 财政年份:2023
- 资助金额:
$ 35.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CRII: RI: Understanding Activities of Daily Living in Indoor Scenarios
CRII:RI:了解室内场景中的日常生活活动
- 批准号:
2245652 - 财政年份:2023
- 资助金额:
$ 35.44万 - 项目类别:
Standard Grant
Sources of vulnerability among those using homecare despite having no limitations in Activities of Daily Living. An intersectionality analysis
尽管日常生活活动没有限制,但使用家庭护理的人的脆弱性来源。
- 批准号:
499112 - 财政年份:2023
- 资助金额:
$ 35.44万 - 项目类别:
Operating Grants
Association between Nursing Care and Prognosis and Activities of Daily Living in Acute Stroke patients by using Big Data.
利用大数据研究急性脑卒中患者的护理与预后和日常生活活动的关系。
- 批准号:
23K16412 - 财政年份:2023
- 资助金额:
$ 35.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of a model of nurses-occupational therapists collaborative practice on activities of daily living in elderly patients
护士-职业治疗师合作实践模式对老年患者日常生活活动的影响
- 批准号:
22K17540 - 财政年份:2022
- 资助金额:
$ 35.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
- 批准号:
10429480 - 财政年份:2022
- 资助金额:
$ 35.44万 - 项目类别:
Assessing a Novel Virtual Environment that Primes Individuals Living with AD/ADRD to Accomplish Activities of Daily Living.
评估一种新颖的虚拟环境,该环境可以帮助 AD/ADRD 患者完成日常生活活动。
- 批准号:
10668160 - 财政年份:2022
- 资助金额:
$ 35.44万 - 项目类别:
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
- 批准号:
10621820 - 财政年份:2022
- 资助金额:
$ 35.44万 - 项目类别: